Hologic Inc (HOLX) Files Form 4 Insider Selling : Nancy Leaming Sells 6,221 Shares

Hologic Inc (HOLX): Nancy Leaming , director of Hologic Inc sold 6,221 shares on Jul 8, 2016. The Insider selling transaction was reported by the company on Jul 12, 2016 to the Securities and Exchange Commission. The shares were sold at $36.03 per share for a total value of $224,211.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 2, 2016, Lawrence M Levy (director) sold 17,794 shares at $34.41 per share price.On May 31, 2016, Peter J. Iii Valenti (Division Pres., Breast Health) sold 10,022 shares at $33.84 per share price.Also, On May 31, 2016, Karleen Marie Oberton (Corp. VP & Chief Acctg Officer) sold 4,228 shares at $33.85 per share price.On May 31, 2016, Elaine Ullian (director) sold 6,896 shares at $33.85 per share price.

Shares of Hologic (HOLX) ended Monday, Jul 11, 2016 session in red amid volatile trading. The shares closed down -0.32 points or -0.89% at $35.61 with 17,79,035 shares getting traded. Post opening the session at $36.1, the shares hit an intraday low of $35.59 and an intraday high of $36.19 and the price vacillated in this range throughout the day. The company has a market cap of $9,929 M and the number of outstanding shares has been calculated to be 27,88,29,790 shares. The 52-week high of Hologic is $43 and the 52-week low is $31.84.

Hologic Money Flow Index Chart

Company has been under the radar of several Street Analysts.Hologic is Downgraded by Needham to Hold. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Apr 28, 2016.

Hologic Inc. is a developer manufacturer and supplier of diagnostics products medical imaging systems and surgical products. The Company’s business units are focused on diagnostics breast health GYN surgical and skeletal health. The Company’s diagnostics products include Aptima family of assays its ThinPrep system the Rapid Fetal Fibronectin Test and its Procleix blood screening assays. The Aptima family of assays is used to detect the infectious microorganisms that cause the common sexually transmitted diseases chlamydia and gonorrhea certain high-risk strains of human papillomavirus (HPV) and Trichomonas vaginalis the parasite that causes trichomoniasis. The Company’s GYN surgical products include its NovaSure Endometrial Ablation System and its MyoSure Hysteroscopic Tissue Removal System. The skeletal health products include dual-energy X-ray bone densitometry systems an ultrasound-based osteoporosis assessment product and its Fluoroscan mini C-arm imaging products.

Leave a Reply

Hologic - Is it time to Sell?

Top Brokerage Firms are advising their investors on Hologic. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.